UNICREDIT BANK/CALL/BRISTOL-MYERS SQUIBB/85/0.1/18.06.25 Stock UNICREDIT BANK/CALL/BRISTOL-MYERS SQUIBB/85/0.1/18.06.25
Add to a list
To use this feature you must be a member
Log inSign up

UNICREDIT BANK/CALL/BRISTOL-MYERS SQUIBB/85/0.1/18.06.25 Share Price

Warrant

DE000HC86KH9

Market Closed - BOERSE MUENCHEN 01:12:19 25/05/2024 am IST
0.007 EUR 0.00% Intraday chart for UNICREDIT BANK/CALL/BRISTOL-MYERS SQUIBB/85/0.1/18.06.25
Current month-30.00%
1 month-72.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart BRISTOL-MYERS SQUIBB COMPANY
Chart UNICREDIT BANK/CALL/BRISTOL-MYERS SQUIBB/85/0.1/18.06.25

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms BU
Bristol-Myers Squibb Unveils Positive Data for KarXT in Schizophrenia Treatment MT
Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting BU
Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million RE
More news

Quotes 5-day view

Date Price Change
24/24/24 0.007 0.00%
23/24/23 0.007 0.00%
22/24/22 0.007 0.00%
21/24/21 0.007 -22.22%
20/24/20 0.009 -18.18%

Real-time BOERSE MUENCHEN

Last update May 25, 2024 at 01:12 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BRISTOL-MYERS SQUIBB COMPANY
IssuerLogo Issuer UniCredit UniCredit
WKN HC86KH
ISINDE000HC86KH9
Date issued 24/07/2023
Strike 85 $
Maturity 18/06/2025 (389 Days)
Parity 10 : 1
Emission price 0.29 €
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.26 €
Lowest since issue 0.001 €

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.
Sector
-
More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Bristol-Myers Squibb Company

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.24 USD
Average target price
53.19 USD
Spread / Average Target
+28.99%
Consensus
  1. Stock Market
  2. Warrants
  3. Warrant